Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesUSANA Health Sciences Inc

USANA Health Sciences Inc

Consumer Defensive Packaged Foods
PortfolioPortfolio WatchlistWatchlist
Company price
13.63 USD -0.23 ( 1.66%)
Last update at 2026-11-06T21:00:00Z
VOLUME
292288
Market Cap
275.30M

Momentum Score

…

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
13.12
Low
13.70
High
52 Week Price Range
12.57
Low
30.93
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

USANA Health Sciences sells nutritional supplements and personal-care products through independent distributors in North America and Asia. Long-term growth may be supported by rising global demand for preventative health, Asian market expansion, product innovation and digital sales tools. Investors may find the company attractive because the direct-selling model can generate recurring revenue, scalable margins and cash flow while keeping variable costs.

Principal risks include reliance on distributor recruitment, regulatory and legal scrutiny of direct-selling practices (notably in China and key markets), competitive pressure and sensitivity to currency and macroeconomic cycles.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
13.86
Dividend Yield
-
Revenue TTM
913.36M
Revenue Per Share
49.73
Gross Profit TTM
707.36M
Debt / Equity
0.03
ROE
-5.06%
Net Debt
-144.38M
ROCE
6.90%
Diluted EPS TTM
-1.15

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 41.53M 76.35M 102.45M 108.62M 170.64M
Minority interest -0.72M -0.03M 0.00M - -
Net income 10.76M 42.03M 63.79M 69.35M 116.50M
Selling general administrative 337.37M 258.30M 256.99M 262.30M 279.11M
Selling and marketing expenses - 368.67M 394.26M 434.79M 519.27M
Gross profit 724.40M 678.75M 731.62M 804.71M 968.57M
Reconciled depreciation 39.70M 22.23M 20.78M 21.41M 22.19M
Ebit 42.37M 76.63M 102.72M 86.20M 148.00M
Ebitda 82.07M 98.86M 123.11M 107.61M 170.19M
Depreciation and amortization 39.70M 22.23M 20.39M 21.41M 22.19M
Non operating income net other - - - - 0.51M
Operating income 50.86M 66.32M 93.07M 107.61M 170.19M
Other operating expenses 874.39M 788.18M 827.94M 890.99M 1016.27M
Interest expense 0.84M 0.28M 0.26M 0.19M 0.06M
Tax provision 30.05M 34.29M 38.83M 39.27M 54.14M
Interest income 2.42M 11.32M 8.19M 3.79M 2.52M
Net interest income 1.57M 11.04M 8.04M 3.60M 2.46M
Income tax expense 30.05M 34.29M 38.66M 39.27M 54.14M
Total revenue 925.26M 854.50M 921.01M 998.60M 1186.46M
Total operating expenses 673.54M 612.43M 638.54M 697.10M 798.37M
Cost of revenue 200.85M 175.75M 189.40M 193.89M 217.90M
Total other income expense net -9.34M 10.03M 9.38M 1.01M 0.45M
Net income from continuing ops 11.48M 42.06M 59.82M 69.35M 116.50M
Net income applicable to common shares - - - 69.35M 116.50M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 742.91M 748.19M 632.76M 596.55M 577.74M
Intangible assets 133.15M 151.82M 29.92M 32.43M 30.44M
Other current assets 27.42M 19.46M 18.67M 28.87M 26.97M
Total liab 156.64M 161.86M 135.56M 162.08M 182.62M
Total stockholder equity 533.10M 532.11M 497.20M 434.47M 395.12M
Deferred long term liab - - - - 7.50M
Other current liab 97.30M 74.82M 74.27M 105.02M 120.57M
Common stock 0.02M 0.02M 0.02M 0.02M 0.02M
Capital stock 0.02M 0.02M 0.02M 0.02M 0.02M
Retained earnings 465.72M 478.94M 445.22M 391.64M 344.64M
Other liab - - - 10.56M 21.83M
Good will 137.96M 144.17M 17.10M 17.37M 17.67M
Other assets - - 0.00M 50.68M 62.73M
Cash 158.38M 181.77M 330.42M 288.42M 239.83M
Total current liabilities 128.56M 139.62M 118.84M 143.83M 160.79M
Current deferred revenue - 12.05M 13.91M 20.88M 19.64M
Net debt -144.38M -142.56M -317.21M -281.53M -232.75M
Short term debt 14.00M 29.01M 8.06M 6.89M 7.08M
Short long term debt 14.00M 23.00M 0.79M - -
Short long term debt total 14.00M 39.20M 13.21M 6.89M 7.08M
Other stockholder equity 83.54M 75.82M 65.66M 55.60M 50.01M
Property plant equipment - - - 111.69M 101.78M
Total current assets 288.40M 279.19M 417.75M 384.38M 365.12M
Net tangible assets - - - 384.67M 347.01M
Net receivables - 8.22M 7.20M 7.21M 7.16M
Inventory 102.61M 69.73M 61.45M 67.09M 98.32M
Accounts payable 17.26M 11.98M 10.07M 11.05M 13.51M
Accumulated other comprehensive income -16.18M -22.67M -13.70M -12.79M 0.46M
Common stock total equity - - - - 0.02M
Retained earnings total equity - - - - 344.64M
Non currrent assets other 51.86M 56.07M 52.07M 54.80M 57.89M
Non current assets total 454.51M 469.01M 215.01M 212.17M 212.62M
Capital lease obligations 5.65M 6.01M 7.28M 6.89M 7.08M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -1.07M -213.09M -7.93M -12.37M -1.44M
Change to liabilities - - - -2.66M -16.03M
Total cashflows from investing activities -10.12M -213.09M -11.97M -12.37M -14.19M
Net borrowings -9.00M 22.22M 0.79M - -
Total cash from financing activities -40.60M 9.55M -14.24M -30.09M -181.41M
Change to operating activities - - - -12.37M -13.79M
Net income 10.76M 42.06M 63.79M 69.35M 116.50M
Change in cash -23.27M -148.74M 41.93M 47.67M -72.28M
Begin period cash flow 184.51M 333.25M 291.32M 243.65M 315.94M
End period cash flow 161.24M 184.51M 333.25M 291.32M 243.65M
Total cash from operating activities 22.35M 60.99M 70.64M 103.90M 121.23M
Depreciation 32.56M 22.23M 20.39M 21.41M 22.19M
Other cashflows from investing activities 3.70M 0.06M 0.01M 4.55M 0.01M
Change to inventory -34.69M -2.12M 2.35M 21.88M -10.50M
Sale purchase of stock -27.51M -9.44M -11.60M -25.38M -177.84M
Other cashflows from financing activities -4.10M -3.22M -3.43M 6.29M -3.58M
Change to netincome - - - 6.29M 11.39M
Capital expenditures 13.82M 10.07M 14.49M 10.40M 12.76M
Cash flows other operating - - - - 6.83M
Cash and cash equivalents changes - - - - -74.37M
Change in working capital -43.08M -13.00M -28.00M 6.85M -28.86M
Stock based compensation 13.83M 14.56M 14.60M 13.33M 14.30M
Other non cash items 15.41M 1.89M 2.61M 0.14M 0.06M
Free cash flow 8.53M 50.92M 56.15M 93.50M 108.46M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
USNA
USANA Health Sciences Inc		 -0.23
1.66%		 13.63 - 8.63 0.30 0.54 0.15 3.19
NSRGF
Nestle SA		 -1.51
1.43%		 104.11 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR		 -2.25
2.11%		 104.18 26.82 18.66 3.18 7.07 3.81 21.70
DANOY
Danone PK		 -0.43
2.79%		 14.96 24.23 17.64 1.88 2.57 1.88 11.70
GPDNF
Danone S.A		 -
-%		 75.84 20.30 14.75 1.65 2.24 1.76 10.92

Profile*

USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

3838 West Parkway Boulevard, Salt Lake City, UT, United States, 84120

801 954 7100

https://www.usana.com

1570

Name Title Year Born
Mr. Kevin G. Guest Chairman & CEO 1963
Mr. Jim Brown Pres 1969
Mr. G. Douglas Hekking Chief Financial Officer 1970
Mr. Walter Noot Chief Operating Officer 1966
Mr. David Mulham Chief Sales Officer 1960
Dr. Myron W. Wentz Founder & Chairman Emeritus 1941
Dr. John Cuomo Exec. Director of Product Devel. & Technology NA
Dr. Robert A. Sinnott Chief Scientific Officer 1965
Mr. Patrique Richards Exec. Director of Investor Relations & Bus. Devel. NA
Mr. P. Joshua Foukas Chief Legal Officer, Gen. Counsel & Corp. Sec. 1976

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…